The use of biomarkers for identifying those at risk of cardiovascular mortality is now central to the management of patients with heart failure. Research now aims to find new, more sensitive markers and more efficient use of existing markers. The ultimate goal is to make earlier and more accurate diagnosis possible, and thereby improve treatment and survival.